Named Bioactive Compounds · Compound
Protocatechuic acid
Moderate Evidencephenolic acid4 PubMed Studies
Hermetica Superfood Encyclopedia
Protocatechuic acid (PCA) is a natural phenolic acid found in fruits, vegetables, and herbs that exerts potent antioxidant activity primarily through direct free radical scavenging and transition metal chelation. Its catechol moiety enables electron donation to neutralize reactive oxygen species including DPPH, ABTS⁺•, superoxide anion, and hydroxyl radicals in a concentration-dependent manner.
Protocatechuic acid (3,4-dihydroxybenzoic acid) is a naturally occurring phenolic compound derived from phenylalanine via the shikimic acid pathway in various plant species. It can be isolated from sources such as dried roselle flowers and is found as a metabolite of polyphenols including phloretin and quercetin in fruits, vegetables, and nuts.
The available research consists primarily of laboratory and cellular studies demonstrating antioxidant, anti-inflammatory, and anticancer properties. No human clinical trials, randomized controlled trials, or meta-analyses with specific PMIDs were found in the provided research dossier.
No clinically studied dosage ranges were provided in the available research for any form of protocatechuic acid (extract, powder, or standardized preparations). Consult a healthcare provider before starting any new supplement.
Protocatechuic acid (3,4-dihydroxybenzoic acid; C₇H₆O₄; MW 154.12 g/mol) is a dihydroxybenzoic acid phenolic compound rather than a food consumed for macronutrient content. It is not a significant source of protein, fat, carbohydrates, fiber, vitamins, or minerals. Its relevance is entirely as a bioactive compound. Key details: • Chemical structure: Benzoic acid with hydroxyl groups at the 3- and 4-positions on the aromatic ring, classifying it as a catechol-type phenolic acid. • Natural occurrence concentrations: Found in numerous plant foods — reported at approximately 0.4–28 mg/100 g in various fruits (e.g., raspberries, blueberries, gooseberries), 1–6 mg/100 g in certain nuts (e.g., almonds, peanuts), up to ~50–90 mg/100 g in certain herbs and spices (e.g., star anise, cinnamon), ~2–10 mg/L in red wine, and notably high in fermented foods such as aged vinegars. It is also a major metabolite of anthocyanins and other complex polyphenols (e.g., cyanidin-3-glucoside) produced by gut microbiota. • Bioavailability: Relatively well absorbed in the gastrointestinal tract compared to larger polyphenols. Studies indicate rapid absorption with peak plasma concentrations typically reached within 0.5–2 hours post-ingestion. Undergoes extensive phase II metabolism (glucuronidation, sulfation, methylation) in the liver and intestinal wall. Major circulating metabolites include protocatechuic acid-3-O-sulfate, protocatechuic acid-4-O-sulfate, and vanillic acid (3-O-methylated form). Renal excretion is a primary elimination route, with urinary recovery of PCA and metabolites reported in the range of 5–30% of ingested anthocyanin dose (as a metabolite). Free PCA has a relatively short plasma half-life (~1–2 hours). • Key bioactive functional groups: The ortho-dihydroxyl (catechol) moiety on the aromatic ring is responsible for its potent radical scavenging capacity (electron/hydrogen donation), metal chelation (forming stable complexes with Fe²⁺, Fe³⁺, Cu²⁺), and redox activity. The carboxylic acid group contributes to water solubility (~1–2 g/100 mL at 20°C) and ionization at physiological pH (pKa values: ~4.5 for -COOH, ~8.7 and ~13.0 for phenolic -OH groups). • Stability: Sensitive to oxidation, light, and alkaline pH. More stable under acidic conditions. Thermal stability is moderate, with some degradation occurring above 150°C. • Caloric contribution: Negligible when consumed as a naturally occurring trace compound in foods (typically <0.01% of dietary energy intake). • No significant vitamin or mineral content intrinsic to the compound itself.
Protocatechuic acid donates hydrogen atoms and electrons via its ortho-dihydroxyl (catechol) aromatic structure to quench DPPH, ABTS⁺•, superoxide anion (O₂⁻•), and hydroxyl radicals (•OH) in a concentration-dependent fashion. It chelates redox-active transition metals Fe²⁺ and Cu²⁺ through its adjacent hydroxyl groups, preventing Fenton-type reactions that would otherwise generate cell membrane-damaging hydroxyl radicals. Additionally, PCA may modulate Nrf2/Keap1 signaling to upregulate endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase, though this pathway remains under active investigation in preclinical models.
The majority of evidence supporting protocatechuic acid's antioxidant properties derives from in-vitro laboratory assays, including DPPH and ABTS radical scavenging models, and cell-free metal chelation studies, which do not directly predict human bioavailability or efficacy. Animal studies in rodents have demonstrated anti-inflammatory and hepatoprotective effects at doses ranging from 50–200 mg/kg body weight, but these findings have not been reliably translated to controlled human trials. Human clinical data on PCA specifically is extremely limited, with most relevant research examining PCA as a metabolite of dietary anthocyanins rather than as a standalone supplement. The overall evidence base remains preliminary, and no standardized human dosing protocol has been established through randomized controlled trials.
Protocatechuic acid is generally considered well-tolerated when consumed through dietary sources such as olives, berries, and whole grains, but isolated high-dose supplemental forms lack robust human safety data. Due to its iron-chelating activity, concurrent use with iron supplements or iron-dependent medications may reduce their absorption and efficacy, warranting caution and potential dose separation. Theoretical interactions exist with anticoagulant drugs such as warfarin, as phenolic acids can modestly influence platelet aggregation pathways, though direct clinical evidence for PCA specifically is absent. Safety during pregnancy and lactation has not been established in controlled studies, and supplemental use during these periods should be avoided until further data are available.
